CEPH

Nil

Contact Details: 27 rue Juliette Dodu PARIS 75010 France Tel: (33) (0)1 53 72 50 00 Fax: (33) (0)1 53 72 51 28 Email: spontini@cephb.fr WWW: www.cephb.fr/

Recent Publications by CEPH:
Sex-specific effect of IL9 polymorphisms on lung function and polysensitization. Sex differences in asthma-associated phenotypes are well known but the...	18th November, 2009	INSERM, U946, Fondation Jean Dausset/CEPH, Paris 75010, France.	Genes Immun. 2009 Sep;10(6):559-65. Epub 2009 Jun 18. DOI Direct Link
Key quality aspect: a fundamental step for quality improvement in a resource-poor setting. The objective of the study is to identify user's perception of key quality...	5th November, 2009	Department of Social and Preventive Medicine, University of Malaya and	Asia Pac J Public Health. 2009 Oct;21(4):477-86. Epub 2009 Aug 10. DOI Direct Link
Malignant pleural mesothelioma cells resist anoikis as quiescent pluricellular aggregates. Pleural fluid accumulation is a frequent clinical observation in diffuse...	19th September, 2009	INSERM, U674, Fondation Jean Dausset-CEPH, IFR105, Paris, France.	Cell Death Differ. 2009 Aug;16(8):1146-55. Epub 2009 Apr 3. DOI Direct Link
The Gene Wiki: community intelligence applied to human gene annotation. Annotating the function of all human genes is a critical, yet formidable,...	17th September, 2009	Genomics Institute of the Novartis Research Foundation, San Diego, CA	Nucleic Acids Res. 2009 Sep 15. DOI Direct Link
On the use of sibling recurrence risks to select environmental factors liable to interact with genetic risk factors. Gene-environment interactions are likely to be involved in the...	9th July, 2009	[1] Faculty of Medicine, University of Paris-Sud, Le Kremlin Bicetre,	Eur J Hum Genet. 2009 Jul 8. DOI Direct Link
→View more CEPH research publications.

Press Releases on CEPH:
Ception Therapeutics and Cephalon Provide Initial Results of a Phase IIb/III Study of CINQUIL in Pediatric Eosinophilic Esophagitis	23rd November, 2009	Cephalon, Inc.	MALVERN, Pa. and FRAZER, Pa., Nov. 23 /PRNewswire-FirstCall/ -- Ception Therapeutics, Inc., a privately held biopharmaceutical company, and Cephalon, Inc. (Nasdaq: CEPH) today announced results from a
Pivotal Data Published in the Journal Cancer Demonstrate that TREANDA Induced Durable Responses in Relapsed Indolent Non-Hodgkin's Lymphoma	5th November, 2009	Cephalon, Inc.	FRAZER, Pa., Nov. 5 /PRNewswire-FirstCall/ -- Cephalon, Inc. (Nasdaq: CEPH) today announced the journal Cancer has published a pivotal study demonstrating that TREANDA® (bendamustine HCl) for
Cephalon, Inc. to Webcast R&D Day	4th November, 2009	Cephalon, Inc.	FRAZER, Pa., Nov. 4 /PRNewswire-FirstCall/ -- Cephalon, Inc. (Nasdaq: CEPH) today announced that its Research and Development Day in New York City, to be held on November 10, 2009, will be webcast
Mayo Clinic Proceedings Publishes Study of NUVIGIL in Patients with Shift Work Disorder	2nd November, 2009	Cephalon, Inc.	FRAZER, Pa., Nov. 2 /PRNewswire-FirstCall/ -- Cephalon, Inc. (Nasdaq: CEPH) today announced that the November issue of Mayo Clinic Proceedings has published data from a pivotal Phase III trial
Cephalon Net Sales Increase 9% and Net Cash from Operations Surpasses $200 Million in the Third Quarter 2009	27th October, 2009	Cephalon, Inc.	FRAZER, Pa., Oct. 27 /PRNewswire-FirstCall/ -- Cephalon, Inc. (Nasdaq: CEPH) today reported third quarter 2009 net sales of $535.2 million, a 9 percent increase compared to net sales of $489.7

BioNews Results for CEPH:
2nd UPDATE: ImmuPharma Falls as Co, Ana	Hemscott:  Nov 19 2009 1:36PM Matching: ceph
Biotech Stocks for a Possible Year-End Rally	Seeking Alpha:  Nov 18 2009 10:35PM Matching: ceph
Cephalon, Barr Reach Agreement On Drug	Investors Business Daily:  Nov 14 2009 2:22AM Matching: ceph
Cephalon, Inc. (CEPH), Barr Pharmaceuticals, Inc. (BRL) Settle Patent Infringement Suit	BioSpace:  Nov 13 2009 3:44PM Matching: ceph
Cephalon Announces Deal With Barr To Settle Patent Infringement Suit - Update	RTTNews.com:  Nov 13 2009 3:53AM Matching: ceph
Promote your company here: BioNewsCast - Press Release Distribution	→View more CEPH news.

CEPH Patents:
US Patent No.	Title
7592437	Genes involved in intestinal inflammatory diseases and use thereof
6963856	Automated price improvement protocol processor
6893611	Automatic device for dispensing samples in liquid medium for use in chemical or biological reactions
6872360	Centrifuging device for laboratory analyzer

BioPortfolio Ltd provides targeted e-mail address lists for the life science sector - we can enable you to contact around 32 individuals from CEPH using this service.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 285 times since April 2007, the link to the organisation's website has been followed 34 times

Search for more companies in PARIS

Search for more companies in

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for CEPH